NewsRoom Articles - Page 1223 of 1409

MondayAug 14, 2017 3:41 pm

Moxian, Inc. (NASDAQ: MOXC) Changes Venue and Record Date for its 2017 General Meeting of Stockholders

Meeting will be at Swissotel in Beijing, China, on September 29 at 10:00 a.m. local time in order to accommodate more shareholders; the new record date is August 30, 2017 SeeThruEquity projects that Moxian revenues will reach $24.1 million by FY2018 Moxian is targeting a Chinese mobile market of 1.3 billion people, the world’s largest Moxian, Inc. (NASDAQ: MOXC) has changed both its venue and record date for its 2017 general meeting of stockholders. The new record date is August 30, 2017, and the location of the meeting has been moved to the Swissotel in Beijing, China, in the Hong…

MondayAug 14, 2017 1:22 pm

ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) Looks Strong for Investors in Booming Canadian Cannabis Market

ABcann’s low current market cap compared to similar companies offers an obvious opportunity for investors ABcann Global is one of Canada’s most dominant growers of medical marijuana and one of the growers to meet Canadian government’s stringent licensing requirements Major expansion of ABcann’s production capacity is underway An interesting opportunity for investors can be found in ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF), a Canadian grower of medical marijuana. ABcann recently acquired ABcann Medicinals and boasts a recent IPO, appointment of a new medical consultant, and major expansion plans. ABcann is new to the public market, having launched its initial…

MondayAug 14, 2017 12:24 pm

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Reaches Agreement with ATERA SAS to Aid INM-750 Research in Pre-Clinical Tests

InMed to test INM-750 in vitro, estimates clinical trials for 2018-2020 ATERA SAS to develop 3D skin models to help pre-clinical tests of INM-750 INM-750 being developed to treat skin disease epidermolysis bullosa, with a successful therapy having potential global market of $1 billion InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a biopharmaceutical company focused on identifying and commercializing prescription drugs using non-THC cannabinoids, recently reached a research and development agreement with tissue engineering company ATERA SAS of France (http://nnw.fm/5t7cL). The fundamental benefits of this agreement for InMed, as it eyes a clinical trial program, are a proprietary assessment tool,…

MondayAug 14, 2017 11:37 am

Regulation Forcing Drug and Cigarette Companies to Be More Responsible is Great News for Lexaria (LXRP), says CEO

In an interview with Stock Day, CEO Chris Bunka of Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) discussed the company’s recent achievements and its plans for the near future. Revenues are climbing, exceeding, so far in 2017, the total for all of 2016, and the potential for further increases is imminent. The company is in negotiation with at least four large pharmaceutical companies to license its technology. The smallest of these could increase revenues by $1 million; the largest could increase revenues by much, much more, according to Bunka. Getting any of these deals signed will boost the bottom line…

MondayAug 14, 2017 10:08 am

AppSwarm, Inc. (SWRM) is “One to Watch”

Multi-billion industry growing at a compound annual growth rate of 31% Unique business plan providing ground-floor investment opportunities Existing portfolio with flagship app once ranking as #1 iOS family game in five countries AppSwarm, Inc. (OTC: SWRM) is a technology development and incubation acceleration company that partners up with developers through joint ventures, royalty agreements, marketing partnerships, and outright purchase agreements. Focusing on the ever-growing mobile applications market, the company provides all the resources needed for engagement, retention, virality and monetization. The global games market generated approximately $100 billion in revenues in 2016, but large global game companies have made…

ThursdayAug 10, 2017 11:11 am

3PEA International, Inc.’s (TPNL) Innovative Payment Solutions Revolutionizing the Way Corporations Engage Clients and Employees

Leading-edge provider of prepaid card programs and processing services Portfolio includes millions of prepaid debit cards Company serves some of the largest pharmaceutical manufacturers in the world Operating at the cutting edge of innovation, 3PEA International, Inc. (OTCQB: TPNL) is a vertically integrated prepaid card programs and processing services provider, offering solutions for corporate, consumer and government applications. The company is revolutionizing the payments market, catering to a variety of users and industries with innovative solutions and options designed to streamline operations, reduce costs, boost revenue, accelerate product adoption and bolster loyalty. A trusted and experienced payment processor and provider…

ThursdayAug 10, 2017 10:53 am

Algae Dynamics Corp. (ADYNF) Hoping US Senate Bill Decriminalizing Marijuana Will Be Successful

Proposed legislation would remove cannabis from the list of Schedule I controlled substances. If successful, it would pave the way for the Canadian company to enter the U.S. market. Unique combination of algae and cannabis oils targeting cancer and mental health disease, making Algae Dynamics a lucrative opportunity for investors. A bill looking to decriminalize marijuana all over the country has recently been introduced in the U.S. Senate, giving fresh hope to legal cannabis businesses that they will be able to expand operations and access federal protections and banking solutions. The bill, titled the Marijuana Justice Act, was introduced by…

ThursdayAug 10, 2017 10:21 am

Global Payout, Inc. (GOHE) is “One to Watch”

Global Payout, Inc. (OTC: GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships. Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform…

ThursdayAug 10, 2017 9:07 am

AppSwarm, Inc. (SWRM) Ahead of the Game as It Seeks to Increase Choice for More than 2 Billion Players

Incubator for developers of mobile apps Digital game industry continues to grow Mobile app development across Apple, RIM, Google and Microsoft Platforms If you think that movies are big business, you’re right. Then what would you say about the digital game industry, which by most accounts is twice or three times as large? Out of a global population of some 7.5 billion, about 2.2 billion (29%) play ‘video’ games. That’s good, since, according to one academic report, ‘playing video games can boost brain power’. So playing digital games is smart as well as fun, which is why AppSwarm, Inc. (OTC:…

WednesdayAug 09, 2017 1:57 pm

ChineseInvestors.com, Inc. (CIIX) Seen Benefitting from Senate Committee Vote for Amendment Protecting Legal Cannabis

Unclear whether amendment will survive in final appropriations bill, but Congressional vote sends message to Attorney General Jeff Sessions CIIX is expanding in global market with online cannabidiol store in Shanghai, China, and brick-and-mortar unit to open in San Gabriel, California Consilium Global Research estimates that CIIX will outperform cannabis market to achieve revenues of $14.8 million by FY 2020 ChineseInvestors.com, Inc. (OTCQB: CIIX) and other cannabis companies were overjoyed by the July 27 affirmative voice vote by the Senate Appropriations Committee to approve an amendment to a “2018 Commerce, Justice and Science Bill” that bars the federal government from…

Financial news and publishing for public and private companies

Contact us: 512.354.7000